Delphinus Medical Technologies is a company that develops, commercializes, sells, and services breast cancer screening solutions to hospitals and imaging clinics internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy.